Summit Trail Advisors LLC cut its stake in shares of Gilead Sciences, Inc. ( NASDAQ:GILD – Get Rating ) by 12.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,915 shares of the biopharmaceutical company's stock after selling 810 shares during the period. Summit Trail Advisors LLC's holdings in Gilead Sciences were worth $508,000 as of its most recent SEC filing. A number of other hedge funds also recently added to or reduced their stakes in the stock.

https://www.dailypolitical.com/2023/04/30/gilead-sciences-inc-nasdaqgild-shares-sold-by-summit-trail-advisors-llc.html

#dailypolitical